Biomerics Welcomes Arun Mohan as New Chief Executive Officer

Biomerics Appoints Arun Mohan as New CEO

On October 6, 2025, Biomerics, a leading contract manufacturer in the interventional medical device sector, officially introduced Arun Mohan as its new Chief Executive Officer (CEO). This change comes as founder Travis Sessions moves to the role of Chairman of the Board, marking a significant shift in leadership as the company evolves in its mission to enhance healthcare through innovative solutions.

A New Era of Leadership
Sessions expressed confidence in Mohan's capabilities, stating, "This is a defining moment in Biomerics' 30-year journey. Our success has always been rooted in innovation, manufacturing excellence, and an unwavering commitment to our customers." Mohan’s prior experience as the President of Biomerics' Micro Metals Division was cited as crucial to his appointment. He built a high-performing team known for exceptional customer satisfaction, operational efficiency, and significant growth.

In his new role, Mohan emphasized that the company's mission to improve and save lives will remain at the forefront of their strategy. He remarked, "I am humbled and honored to lead Biomerics into its next chapter. We will continue to place our customers at the center of our operations, invest in our employees, and advance our manufacturing excellence expectations."

Vision for the Future
Mohan’s leadership philosophy centers on customer-centricity, employee empowerment, and innovation. He expressed an intention of not just leading Biomerics in medtech manufacturing but also fostering a culture that instills pride in employees and confidence in customers.

Travis Sessions, who founded Biomerics in 1994, grew the company from a single-site operation to a formidable partner in the industry with over 3,000 employees across 12 locations in the U.S., Dominican Republic, and Costa Rica. As Chairman, Sessions plans to stay involved in guiding Mohan through strategic initiatives, including potential mergers and acquisitions.

Biomerics: A Trusted Partner in Medical Devices
Established in 1994, Biomerics has positioned itself as a premier vertically integrated contract manufacturer in the interventional device market. The firm proudly serves 20 of the top 30 medical device OEMs globally, offering services that range from engineering design and development to manufacturing, sterilization, and packaging of medical device components and devices. This vast expertise places Biomerics at the forefront of medical technology innovation.

With its operations spread across nine facilities in the United States and additional centers in Costa Rica and the Dominican Republic, Biomerics is committed to addressing its clients' immediate and long-term needs efficiently. The company remains at the cutting edge of engineering, specializing in performance materials, interventional medical plastics, precision extrusion, micromachining, and advanced catheter technology.

A Commitment to Quality and Compliance
Biomerics operates under a comprehensive ISO 13485:2016 quality system and is fully compliant with FDA regulations, ensuring the highest standards in medical device manufacturing. This dedication to quality and regulatory compliance underscores Biomerics' commitment to offering safe and effective solutions that truly impact patient care.

In conclusion, Arun Mohan’s appointment as CEO heralds a new chapter for Biomerics, promising continued growth and innovation within a company already recognized for its engineering excellence and customer-centric philosophy. With a seasoned leader at the helm and a strong foundation laid by the founder, stakeholders can look forward to an exciting future for Biomerics in the healthcare industry.